Amid a backlash against foreign investors, some executives are banned from leaving the country
The Camry, last overhauled for the 2011 model year, just got another face-lift
Laws require companies to pay state taxes on sheltered profits
Financial filings reveal the pay package Henrique de Castro received upon exit from the company.
Wal-Mart's new money transfers shows how the retailer can use its reach to push down costs
Skipping Rocks Lab develops a green alternative to all that plastic
Alessandro Borgognone wooed Japanese chef Daisuke Nakazawa to open the four-star New York eatery
Administrators quashed their food delivery service. Now they're focusing on other colleges
Prices are low, but there’s plenty of red tape
Founders: Dr. Daniel J. Abrams; Tom Anchordoquy, PhD; and Karen Stevens, PhD
VC Investment over the last four quarters: $21.5 million
Founded in 2005, this seven-person biopharmaceutical company develops drugs for the treatment of severe central nervous system diseases. In addition to VC funding, Sierra received about $230,000 in grants from the State of Colorado, the University of Colorado, and the Coleman Institute. As for the recession, its founders say the company will be keeping close tabs on the funding and partnership environment over the next two to three years, despite already being funded for drug development work for the next three years.
Key to startup success: "Be persistent in the development of your data and business model to enable you to create a financial model that has a high likelihood of helping patients and therefore is fundable by the investor community."